# A Prospective, Multicenter, Randomized Controlled Trial to Evaluate the Efficacy and Safety of Amnion Membrane Disc Allograft Versus Standard of Care in Participants With Moderate to Severe Dry Eye Disease

> **NCT07529899** · PHASE3 · NOT_YET_RECRUITING · sponsor: **Cellution Biologics** · enrollment: 40 (estimated)

## Conditions studied

- Dry Eye Disease (DED)

## Interventions

- **PROCEDURE:** Standard of Care (SOC)
- **OTHER:** Lyophilized Amnion Membrane Disc Allograft

## Key facts

- **NCT ID:** NCT07529899
- **Lead sponsor:** Cellution Biologics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-07
- **Primary completion:** 2026-12
- **Final completion:** 2026-12
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2026-04-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07529899

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07529899, "A Prospective, Multicenter, Randomized Controlled Trial to Evaluate the Efficacy and Safety of Amnion Membrane Disc Allograft Versus Standard of Care in Participants With Moderate to Severe Dry Eye Disease". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07529899. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*